MED Q1 2026 Earnings EPS Surprises to the Upside but Stock Declines Fulcrum Therapeutics Q1 2026 Earnings Narrowing Losses as Pipeline Advances GNLN Q2 2023 Earnings Deep EPS Miss Triggers Selloff RANI Q1 2026 Earnings Narrowing Losses as Pipeline Progress Continues HOVR Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage UWMC Q1 2026 Earnings EPS Surprises to the Upside as Mortgage Market Stabilizes